Ampersand Wants to Add $400 Million
Wade Roush7/31/08
Wellesley, MA-based private equity firm Ampersand Ventures, which invests in pharmaceutical, medical device, manufacturing, and enterprise software companies, has embarked on fundraising for a new fund targeted at $400 million, according to a report today at PE Hub. It’s been two years since the firm raised its current $212 million fund.
Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can e-mail him at wroush@xconomy.com or follow him on Twitter at twitter.com/wroush.
